| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer
|
Uemura, Takehiro
|
|
2019
|
84 |
6 |
p. 1229-1239
|
artikel
|
| 2 |
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
|
Morrissey, Kari M.
|
|
2019
|
84 |
6 |
p. 1257-1267
|
artikel
|
| 3 |
Alternative dosing regimens for atezolizumab: right dose, wrong frequency
|
Goldstein, Daniel A.
|
|
2019
|
84 |
6 |
p. 1153-1155
|
artikel
|
| 4 |
A phase I delayed-start, randomized and pharmacodynamic study of metformin and chemotherapy in patients with solid tumors
|
Saif, Mohammad Wasif
|
|
2019
|
84 |
6 |
p. 1323-1331
|
artikel
|
| 5 |
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
|
Lubberman, Floor J. E.
|
|
2019
|
84 |
6 |
p. 1179-1185
|
artikel
|
| 6 |
A reliable method to determine which candidate chemotherapeutic drugs effectively inhibit tumor growth in patient-derived xenografts (PDX) in single mouse trials
|
Gordon, Derek
|
|
2019
|
84 |
6 |
p. 1167-1178
|
artikel
|
| 7 |
BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells
|
Yang, Wei
|
|
2019
|
84 |
6 |
p. 1279-1288
|
artikel
|
| 8 |
Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1
|
Turan, Caner
|
|
2019
|
84 |
6 |
p. 1333-1338
|
artikel
|
| 9 |
Combined thermo-chemotherapy of cancer using 1 MHz ultrasound waves and a cisplatin-loaded sonosensitizing nanoplatform: an in vivo study
|
Irajirad, Rasoul
|
|
2019
|
84 |
6 |
p. 1315-1321
|
artikel
|
| 10 |
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
|
Rivera, Fernando
|
|
2019
|
84 |
6 |
p. 1365
|
artikel
|
| 11 |
Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer
|
Sun, Yuliang
|
|
2019
|
84 |
6 |
p. 1241-1256
|
artikel
|
| 12 |
Dihydropyrimidine dehydrogenase in the metabolism of the anticancer drugs
|
Sharma, Vinay
|
|
2019
|
84 |
6 |
p. 1157-1166
|
artikel
|
| 13 |
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy
|
Crucitta, Stefania
|
|
2019
|
84 |
6 |
p. 1219-1227
|
artikel
|
| 14 |
Enhancing intratumoral biodistribution and antitumor activity of nab-paclitaxel through combination with a vascular disrupting agent, combretastatin A-4-phosphate
|
Gao, Meng
|
|
2019
|
84 |
6 |
p. 1187-1194
|
artikel
|
| 15 |
JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer
|
Yoshino, Takayuki
|
|
2019
|
84 |
6 |
p. 1269-1277
|
artikel
|
| 16 |
Metformin plus first-line chemotherapy versus chemotherapy alone in the treatment of epithelial ovarian cancer: a prospective open-label pilot trial
|
Zheng, Ya
|
|
2019
|
84 |
6 |
p. 1349-1357
|
artikel
|
| 17 |
NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells
|
Liu, Ling
|
|
2019
|
84 |
6 |
p. 1303-1314
|
artikel
|
| 18 |
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial
|
Luu, Thehang
|
|
2019
|
84 |
6 |
p. 1201-1208
|
artikel
|
| 19 |
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
|
Appleman, Leonard J.
|
|
2019
|
84 |
6 |
p. 1289-1301
|
artikel
|
| 20 |
Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients
|
Kawakatsu, Sonoko
|
|
2019
|
84 |
6 |
p. 1339-1348
|
artikel
|
| 21 |
Prevalence of the DPYD variant (Y186C) in Brazilian individuals of African ancestry
|
Cunha-Junior, Geraldo Felício
|
|
2019
|
84 |
6 |
p. 1359-1363
|
artikel
|
| 22 |
RETRACTED ARTICLE: NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells
|
Liu, Ling
|
|
|
84 |
6 |
p. 1303-1314
|
artikel
|
| 23 |
Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy
|
Cao, Yanshuo
|
|
2019
|
84 |
6 |
p. 1195-1200
|
artikel
|
| 24 |
Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway
|
Zhang, Yanshan
|
|
2019
|
84 |
6 |
p. 1209-1218
|
artikel
|
Tijdschrift beschrijving